(BRCC) BRC - Overview
Stock: Coffee, Apparel, Gear, Media, Energy
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 91.2% |
| Relative Tail Risk | -13.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.19 |
| Alpha | -83.28 |
| Character TTM | |
|---|---|
| Beta | 0.958 |
| Beta Downside | 0.693 |
| Drawdowns 3y | |
|---|---|
| Max DD | 90.69% |
| CAGR/Max DD | -0.56 |
Description: BRCC BRC January 17, 2026
BRC Inc. (NYSE: BRCC) operates a vertically integrated coffee business in the United States, purchasing green coffee beans, roasting them, and selling both coffee and related accessories. Its product portfolio spans apparel, brewing equipment, ready-to-drink energy beverages, outdoor-lifestyle gear, and proprietary media content, distributed through wholesale partners, direct-to-consumer outlets, branded outposts, and e-commerce sites. The company was founded in 2014 and is headquartered in Salt Lake City, Utah.
According to the most recent Form 10-K (FY 2023), BRC reported net revenue of approximately **$185 million**, a **12 % year-over-year increase** driven primarily by higher same-store sales and accelerated online growth. Gross margin expanded to **38 %**, up from 34 % the prior year, reflecting improved roasting efficiency and a shift toward higher-margin ready-to-drink products. The company’s cash conversion cycle shortened to **45 days**, indicating tighter working-capital management.
Key macro drivers for BRC include the **U.S. specialty coffee market’s 6-7 % CAGR** over the past five years, sustained consumer willingness to spend on premium coffee experiences despite recent inflationary pressures, and the **continued shift toward e-commerce**, which now accounts for roughly **30 % of total sales** for the sector. A potential risk is the sensitivity of discretionary spending to interest-rate-driven consumer tightening, which could compress margins if price elasticity intensifies.
For a deeper dive into BRC’s valuation metrics, competitive positioning, and scenario analysis, the ValueRay platform provides a concise, data-rich overview worth exploring.
Piotroski VR‑10 (Strict, 0-10) 1.5
| Net Income: -11.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA -5.53 > 1.0 |
| NWC/Revenue: 6.96% < 20% (prev 3.06%; Δ 3.90% < -1%) |
| CFO/TA 0.00 > 3% & CFO 1.07m > Net Income -11.2m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.34 > 1.5 & < 3 |
| Outstanding Shares: last quarter (79.1m) vs 12m ago 9.69% < -2% |
| Gross Margin: 36.33% > 18% (prev 0.38%; Δ 3595 % > 0.5%) |
| Asset Turnover: 171.6% > 50% (prev 173.4%; Δ -1.80% > 0%) |
| Interest Coverage Ratio: -2.34 > 6 (EBITDA TTM -10.1m / Interest Expense TTM 10.4m) |
Altman Z'' -2.79
| A: 0.12 (Total Current Assets 108.6m - Total Current Liabilities 81.3m) / Total Assets 222.4m |
| B: -0.59 (Retained Earnings -132.1m / Total Assets 222.4m) |
| C: -0.11 (EBIT TTM -24.5m / Avg Total Assets 228.0m) |
| D: -0.89 (Book Value of Equity -132.1m / Total Liabilities 148.2m) |
| Altman-Z'' Score: -2.79 = D |
Beneish M -2.85
| DSRI: 1.09 (Receivables 30.4m/28.9m, Revenue 391.4m/405.3m) |
| GMI: 1.04 (GM 36.33% / 37.62%) |
| AQI: 1.26 (AQ_t 0.20 / AQ_t-1 0.16) |
| SGI: 0.97 (Revenue 391.4m / 405.3m) |
| TATA: -0.06 (NI -11.2m - CFO 1.07m) / TA 222.4m) |
| Beneish M-Score: -2.85 (Cap -4..+1) = A |
What is the price of BRCC shares?
Over the past week, the price has changed by -2.78%, over one month by -19.07%, over three months by -34.48% and over the past year by -66.98%.
Is BRCC a buy, sell or hold?
- StrongBuy: 3
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the BRCC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 2.2 | 161.4% |
| Analysts Target Price | 2.2 | 161.4% |
| ValueRay Target Price | 0.5 | -43.4% |
BRCC Fundamental Data Overview February 03, 2026
P/S = 0.2423
P/B = 1.9733
Revenue TTM = 391.4m USD
EBIT TTM = -24.5m USD
EBITDA TTM = -10.1m USD
Long Term Debt = 32.9m USD (from longTermDebt, last quarter)
Short Term Debt = 4.62m USD (from shortTermDebt, last quarter)
Debt = 62.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 53.4m USD (from netDebt column, last quarter)
Enterprise Value = 199.1m USD (145.6m + Debt 62.9m - CCE 9.48m)
Interest Coverage Ratio = -2.34 (Ebit TTM -24.5m / Interest Expense TTM 10.4m)
EV/FCF = -55.99x (Enterprise Value 199.1m / FCF TTM -3.56m)
FCF Yield = -1.79% (FCF TTM -3.56m / Enterprise Value 199.1m)
FCF Margin = -0.91% (FCF TTM -3.56m / Revenue TTM 391.4m)
Net Margin = -2.86% (Net Income TTM -11.2m / Revenue TTM 391.4m)
Gross Margin = 36.33% ((Revenue TTM 391.4m - Cost of Revenue TTM 249.2m) / Revenue TTM)
Gross Margin QoQ = 36.89% (prev 33.92%)
Tobins Q-Ratio = 0.90 (Enterprise Value 199.1m / Total Assets 222.4m)
Interest Expense / Debt = 2.72% (Interest Expense 1.71m / Debt 62.9m)
Taxrate = 21.0% (US default 21%)
NOPAT = -19.3m (EBIT -24.5m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.34 (Total Current Assets 108.6m / Total Current Liabilities 81.3m)
Debt / Equity = 1.31 (Debt 62.9m / totalStockholderEquity, last quarter 48.0m)
Debt / EBITDA = -5.28 (negative EBITDA) (Net Debt 53.4m / EBITDA -10.1m)
Debt / FCF = -15.03 (negative FCF - burning cash) (Net Debt 53.4m / FCF TTM -3.56m)
Total Stockholder Equity = 20.6m (last 4 quarters mean from totalStockholderEquity)
RoA = -4.91% (Net Income -11.2m / Total Assets 222.4m)
RoE = -54.27% (Net Income TTM -11.2m / Total Stockholder Equity 20.6m)
RoCE = -45.77% (EBIT -24.5m / Capital Employed (Equity 20.6m + L.T.Debt 32.9m))
RoIC = -23.87% (negative operating profit) (NOPAT -19.3m / Invested Capital 81.0m)
WACC = 7.24% (E(145.6m)/V(208.5m) * Re(9.44%) + D(62.9m)/V(208.5m) * Rd(2.72%) * (1-Tc(0.21)))
Discount Rate = 9.44% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 13.49%
Fair Price DCF = unknown (Cash Flow -3.56m)
EPS Correlation: -46.14 | EPS CAGR: -63.41% | SUE: -0.19 | # QB: 0
Revenue Correlation: 71.82 | Revenue CAGR: 9.42% | SUE: -0.12 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.01 | Chg30d=-0.002 | Revisions Net=+1 | Analysts=2
EPS next Year (2026-12-31): EPS=-0.01 | Chg30d=-0.003 | Revisions Net=+1 | Growth EPS=+83.3% | Growth Revenue=+11.1%